Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia

Br J Haematol. 2017 Dec;179(5):849-851. doi: 10.1111/bjh.14266. Epub 2016 Sep 8.

Affiliation

¹ Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

PMID: 27605200
DOI: 10.1111/bjh.14266

No abstract available

Keywords: Diagnosis; IgM monoclonal gammopathy; MYD88 mutation; Prognosis; Waldenström macroglobulinaemia.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immunoglobulin M / blood
Monoclonal Gammopathy of Undetermined Significance / diagnosis
Monoclonal Gammopathy of Undetermined Significance / epidemiology*
Monoclonal Gammopathy of Undetermined Significance / genetics*
Monoclonal Gammopathy of Undetermined Significance / mortality
Mutation*
Myeloid Differentiation Factor 88 / genetics*
Prevalence
Prognosis
Smoldering Multiple Myeloma / diagnosis
Smoldering Multiple Myeloma / epidemiology*
Smoldering Multiple Myeloma / genetics*
Smoldering Multiple Myeloma / mortality
Survival Rate
Waldenstrom Macroglobulinemia / diagnosis
Waldenstrom Macroglobulinemia / epidemiology*
Waldenstrom Macroglobulinemia / genetics*
Waldenstrom Macroglobulinemia / mortality

Substances

Immunoglobulin M
Myeloid Differentiation Factor 88